MARKET

ECOR

ECOR

Electrocore
NASDAQ

Real-time Quotes | Nasdaq Last Sale

0.9300
-0.0200
-2.11%
After Hours: 0.9120 -0.018 -1.94% 17:53 05/28 EDT
OPEN
0.9000
PREV CLOSE
0.9500
HIGH
0.9450
LOW
0.8900
VOLUME
316.99K
TURNOVER
--
52 WEEK HIGH
5.64
52 WEEK LOW
0.3201
MARKET CAP
33.06M
P/E (TTM)
-0.6985
1D
5D
1M
3M
1Y
5Y

Analyst Rating

Based on 5 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average ECOR stock price target is 4.500 with a high estimate of 8.00 and a low estimate of 1.500.

EPS

ECOR News

More
28 Stocks Moving in Thursday's Pre-Market Session
Gainers
Benzinga · 17h ago
Electrocore, Inc Files Prospectus Relates To Up To 4.1M Shares Of Common Stock, That Selling May Sell From Time To Time In One Or More Transaction
Benzinga · 1d ago
CODX, FTCH among premarket losers
Seeking Alpha - Article · 05/15 13:17
electroCore, Inc. (ECOR) CEO Dan Goldberger on Q1 2020 Results - Earnings Call Transcript
Seeking Alpha - Transcript · 05/15 02:51
ElectroCore, Inc. (ECOR) Reports Q1 Loss, Tops Revenue Estimates
electroCore, Inc. (ECOR) delivered earnings and revenue surprises of -4.00% and 0.55%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
Zacks · 05/14 21:55
electroCore Announces First Quarter Financial Results
GlobeNewswire · 05/14 21:05
electroCore to Announce First Quarter Ended March 31, 2020 Financial Results on Thursday, May 14
BASKING RIDGE, N.J., May 07, 2020 -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, announced that it will report financial results for.
GlobeNewswire · 05/07 12:00
CMG, CLDX among premarket gainers
Seeking Alpha - Article · 04/22 13:19

Industry

Medical Equipment, Supplies & Distribution
+1.37%
Healthcare Equipment & Supplies
+1.61%

Hot Stocks

Symbol
Price
%Change

About ECOR

ElectroCore, Inc., formerly ElectroCore LLC, is a commercial-stage bioelectronic medicine healthcare company. The Company is engaged in developing non-invasive vagus nerve stimulation (nVNS) therapy for the treatment of multiple conditions in neurology, psychiatry, gastroenterology and respiratory fields. The Company's gammaCore is a simple-to-use hand-held device that provides non-invasive dispensing therapy, which stimulates the cervical branch of the vagus nerve. The gammaCore is a non-drug treatment for adults who suffer from episodic cluster and migraine pain. The Company's target is the treatment of primary headaches (migraine and cluster headache), and the associated chronic co-morbidities of gastric motility, psychiatric, sleep and pain disorders.
More

Webull offers kinds of electroCore, Inc. stock information, including NASDAQ:ECOR real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ECOR stock news, and many more online research tools to help you make informed decisions.